Loading subcategories...
Discover Factocel IX coagulation factor injection formulated for the treatment and prevention of bleeding episodes in patients with hemophilia B. Designed for controlled medical use, it supports clotting factor replacement therapy in hospital and specialized care settings. Produced under stringent pharmaceutical controls, it is suitable for bulk institutional procurement and regulated medical distribution.
| Additional Information | |
|---|---|
| Country of Origin | India |
| Customisable | No |
| Available Stock | In Stock |
| Sample Availability | No |
| Payment Terms |
|
| Payment Methods |
|

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.